PROM1 and glioblastoma: In GBM neurospheres and xenografts, Notch blockade via gamma-secretase inhibitors (GSIs) depleted CD133+ cells, reduced clonogenicity, suppressed xenograft growth, and prolonged survival, with decreased AKT/STAT3 signaling.